Sign up to save your podcasts
Or
Share 10,000 Customers. $70M Valuation. No Venture Capital.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
10,000 Customers. $70M Valuation. No Venture Capital.
Daniel Rudyak built a healthcare company the hard way.
No venture capital. No safety net. And for a long stretch, not even the freedom to buy “two tacos” without doing the mental math.
In this episode, Jerome Myers talks with Daniel, founder of ReadyRx, about what it takes to go from private equity boardrooms to the chaos of building: 120-hour weeks, 18 months pre-revenue, and the constant pressure of carrying a mission that’s deeply personal.
ReadyRx has grown to 10,000+ monthly customers and a reported $70M valuation, but this conversation isn’t about hype. It’s about the truth founders rarely say out loud:
the climb is hard, the summit is brief, and the “money” doesn’t give you what you think it will.
If you’re chasing an exit, thinking about raising capital, or worried about what happens after the deal closes, press play.
In this episode:
Why ReadyRx exists (and the healthcare failures that sparked it)
The real difference between investing in businesses and building one
Why they refused venture money and what control is worth
The hidden skill founders need after liquidity: allocation, not adrenaline
Why most people don’t break on the way up, they break on the way down
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Jerome Myers - Advisor to exiting founders
5
6464 ratings
Daniel Rudyak built a healthcare company the hard way.
No venture capital. No safety net. And for a long stretch, not even the freedom to buy “two tacos” without doing the mental math.
In this episode, Jerome Myers talks with Daniel, founder of ReadyRx, about what it takes to go from private equity boardrooms to the chaos of building: 120-hour weeks, 18 months pre-revenue, and the constant pressure of carrying a mission that’s deeply personal.
ReadyRx has grown to 10,000+ monthly customers and a reported $70M valuation, but this conversation isn’t about hype. It’s about the truth founders rarely say out loud:
the climb is hard, the summit is brief, and the “money” doesn’t give you what you think it will.
If you’re chasing an exit, thinking about raising capital, or worried about what happens after the deal closes, press play.
In this episode:
Why ReadyRx exists (and the healthcare failures that sparked it)
The real difference between investing in businesses and building one
Why they refused venture money and what control is worth
The hidden skill founders need after liquidity: allocation, not adrenaline
Why most people don’t break on the way up, they break on the way down
Learn more about your ad choices. Visit megaphone.fm/adchoices